vs

Side-by-side financial comparison of Stellar Bancorp, Inc. (STEL) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $108.9M, roughly 1.3× Stellar Bancorp, Inc.). Stellar Bancorp, Inc. runs the higher net margin — 24.0% vs -5.3%, a 29.3% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 0.8%). Stellar Bancorp, Inc. produced more free cash flow last quarter ($92.6M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 0.2%).

Stellar Bancorp, Inc. is a United States-based financial holding company that operates via its wholly-owned banking subsidiary. It provides a full suite of retail and commercial banking services, including deposit products, personal and commercial loans, mortgage services, and wealth management solutions, serving individual consumers, small businesses, and regional corporate clients.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

STEL vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.3× larger
TOI
$142.0M
$108.9M
STEL
Growing faster (revenue YoY)
TOI
TOI
+40.7% gap
TOI
41.6%
0.8%
STEL
Higher net margin
STEL
STEL
29.3% more per $
STEL
24.0%
-5.3%
TOI
More free cash flow
STEL
STEL
$90.4M more FCF
STEL
$92.6M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
0.2%
STEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
STEL
STEL
TOI
TOI
Revenue
$108.9M
$142.0M
Net Profit
$26.1M
$-7.5M
Gross Margin
Operating Margin
29.0%
-4.9%
Net Margin
24.0%
-5.3%
Revenue YoY
0.8%
41.6%
Net Profit YoY
3.7%
43.0%
EPS (diluted)
$0.52
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STEL
STEL
TOI
TOI
Q4 25
$108.9M
$142.0M
Q3 25
$105.6M
$136.6M
Q2 25
$104.1M
$119.8M
Q1 25
$104.8M
$104.4M
Q4 24
$108.0M
$100.3M
Q3 24
$107.8M
$99.9M
Q2 24
$106.8M
$98.6M
Q1 24
$108.4M
$94.7M
Net Profit
STEL
STEL
TOI
TOI
Q4 25
$26.1M
$-7.5M
Q3 25
$25.7M
$-16.5M
Q2 25
$26.4M
$-17.0M
Q1 25
$24.7M
$-19.6M
Q4 24
$25.2M
$-13.2M
Q3 24
$33.9M
$-16.1M
Q2 24
$29.8M
$-15.5M
Q1 24
$26.1M
$-19.9M
Operating Margin
STEL
STEL
TOI
TOI
Q4 25
29.0%
-4.9%
Q3 25
30.5%
-5.9%
Q2 25
31.7%
-9.4%
Q1 25
29.6%
-9.5%
Q4 24
29.4%
-11.9%
Q3 24
39.6%
-13.9%
Q2 24
35.1%
-16.6%
Q1 24
30.4%
-19.0%
Net Margin
STEL
STEL
TOI
TOI
Q4 25
24.0%
-5.3%
Q3 25
24.3%
-12.1%
Q2 25
25.3%
-14.2%
Q1 25
23.6%
-18.8%
Q4 24
23.3%
-13.1%
Q3 24
31.4%
-16.1%
Q2 24
27.9%
-15.7%
Q1 24
24.1%
-21.0%
EPS (diluted)
STEL
STEL
TOI
TOI
Q4 25
$0.52
$-0.04
Q3 25
$0.50
$-0.14
Q2 25
$0.51
$-0.15
Q1 25
$0.46
$-0.21
Q4 24
$0.47
$-0.14
Q3 24
$0.63
$-0.18
Q2 24
$0.56
$-0.17
Q1 24
$0.49
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STEL
STEL
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$419.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
$-15.7M
Total Assets
$10.8B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STEL
STEL
TOI
TOI
Q4 25
$419.5M
Q3 25
$728.4M
Q2 25
$578.1M
Q1 25
$560.6M
Q4 24
$911.2M
Q3 24
$516.2M
Q2 24
$490.3M
$9.9M
Q1 24
$399.7M
$29.8M
Stockholders' Equity
STEL
STEL
TOI
TOI
Q4 25
$1.7B
$-15.7M
Q3 25
$1.7B
$-12.3M
Q2 25
$1.6B
$-9.0M
Q1 25
$1.6B
$5.1M
Q4 24
$1.6B
$3.6M
Q3 24
$1.6B
$15.5M
Q2 24
$1.6B
$29.2M
Q1 24
$1.5B
$41.3M
Total Assets
STEL
STEL
TOI
TOI
Q4 25
$10.8B
$164.7M
Q3 25
$10.6B
$163.6M
Q2 25
$10.5B
$159.8M
Q1 25
$10.4B
$164.0M
Q4 24
$10.9B
$172.7M
Q3 24
$10.6B
$179.2M
Q2 24
$10.7B
$179.6M
Q1 24
$10.7B
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STEL
STEL
TOI
TOI
Operating Cash FlowLast quarter
$97.0M
$3.2M
Free Cash FlowOCF − Capex
$92.6M
$2.2M
FCF MarginFCF / Revenue
85.0%
1.5%
Capex IntensityCapex / Revenue
4.0%
0.7%
Cash ConversionOCF / Net Profit
3.71×
TTM Free Cash FlowTrailing 4 quarters
$173.2M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STEL
STEL
TOI
TOI
Q4 25
$97.0M
$3.2M
Q3 25
$63.6M
$-12.6M
Q2 25
$25.8M
$-10.2M
Q1 25
$-5.7M
$-5.0M
Q4 24
$132.6M
$4.2M
Q3 24
$59.5M
$819.0K
Q2 24
$38.1M
$-15.7M
Q1 24
$31.1M
$-15.9M
Free Cash Flow
STEL
STEL
TOI
TOI
Q4 25
$92.6M
$2.2M
Q3 25
$62.5M
$-13.2M
Q2 25
$24.5M
$-11.4M
Q1 25
$-6.4M
$-5.3M
Q4 24
$128.0M
$2.4M
Q3 24
$57.7M
$417.0K
Q2 24
$37.1M
$-17.5M
Q1 24
$30.5M
$-16.5M
FCF Margin
STEL
STEL
TOI
TOI
Q4 25
85.0%
1.5%
Q3 25
59.2%
-9.7%
Q2 25
23.6%
-9.5%
Q1 25
-6.2%
-5.1%
Q4 24
118.5%
2.4%
Q3 24
53.5%
0.4%
Q2 24
34.8%
-17.7%
Q1 24
28.2%
-17.4%
Capex Intensity
STEL
STEL
TOI
TOI
Q4 25
4.0%
0.7%
Q3 25
1.1%
0.4%
Q2 25
1.2%
1.0%
Q1 25
0.7%
0.3%
Q4 24
4.3%
1.8%
Q3 24
1.7%
0.4%
Q2 24
0.9%
1.9%
Q1 24
0.5%
0.6%
Cash Conversion
STEL
STEL
TOI
TOI
Q4 25
3.71×
Q3 25
2.48×
Q2 25
0.98×
Q1 25
-0.23×
Q4 24
5.26×
Q3 24
1.76×
Q2 24
1.28×
Q1 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STEL
STEL

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons